^a Tested in dextrose 5%.

^b Tested in sodium chloride 0.9%.

^c Tested in bacteriostatic sodium chloride 0.9% preserved with benzyl alcohol 0.9%.

^d Lyophilized formulation tested.

^e Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.

^f Test performed using the formulation WITHOUT edetate disodium.

^g Tested in Ringer’s injection, lactated.

^h Piperacillin component. Piperacillin in an 8:1 fixed-ratio concentration with tazobactam.

ⁱ Tested in both dextrose 5% and sodium chloride 0.9%.

^j Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

^k Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

^l Test performed using the formulation WITH edetate disodium.

^m Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.

ⁿ Salt not specified.

^o Subvisible particulate test methods include light obscuration, flow imaging microscopy, and backgrounded membrane imaging.

^p Ampicillin component. Ampicillin in a 2:1 fixed-ratio concentration with sulbactam.

^q Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.

^r Intralipid product.

^s SMOFlipid product.